QNRX QUOIN PHARMACEUTICALS LTD
FollowSPONSORED ADS (ADR), issuer CIK 1671502
1 manager (1 13F filer) reported a position in QNRX shares at 2025-03-31, 108 shares in all. 1 filer opened a position and 0 filers sold out during the quarter.
- Managers
- 1
- 13F filers
- 1
- New
- 1
- Added
- 0
- Reduced
- 0
- Sold out
- 0
- Shares held by filers
- 108
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Ikarian Capital, LLC(group Ikarian Capital, LLC)
211,538 shares, 4.4% in a 13G/A as of 2026-09-30,0001778253-26-000004
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q1 2025
Filers in the available 13F reports with a share position at 2025-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 108 | $24 | <0.01% | new | 13F-HRTimeline |
Events
Ikarian Capital, LLC and 1 other reporting person reported 211,538 QNRX shares, 4.4% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-07. 0001778253-26-000004
Accepted , ingested